Description

Gilternib 40mg Tablet (Gilteritinib) – Uses, Side Effects, Dosage & Price in Pakistan

Gilternib 40mg Tablet contains gilteritinib, an oral kinase inhibitor used in the treatment of certain adults with relapsed or refractory acute myeloid leukemia (AML) when the leukemia has a FLT3 mutation. Gilteritinib works by blocking FLT3 signaling, which can help slow the growth and survival of abnormal leukemia cells.

What Is Gilternib 40mg Tablet?

Gilternib 40mg Tablet is an oral anticancer medicine associated with the active ingredient gilteritinib. Gilteritinib belongs to a group of medicines called kinase inhibitors and specifically targets FLT3 signaling.

The 40mg strength is commonly used as part of the prescribed daily dose. Because this is a prescription cancer medicine, treatment should be started and monitored by an experienced oncologist.

Gilternib 40mg (Gilteritinib) Uses

Gilternib 40mg may be used for adults with relapsed or refractory AML that has a FLT3 mutation confirmed through an appropriate diagnostic test. Relapsed AML means the disease has returned after treatment, while refractory AML means it has not responded adequately to previous treatment.

The medicine is designed for patients whose leukemia cells carry specific FLT3 abnormalities. A healthcare professional normally confirms the mutation before selecting gilteritinib treatment.

How Does Gilternib 40mg Work?

Gilteritinib blocks several receptor tyrosine kinases, including FMS-like tyrosine kinase 3 (FLT3). Certain FLT3 mutations can promote abnormal signaling and growth of leukemia cells.

By inhibiting FLT3 signaling, gilteritinib can interfere with the growth and survival of FLT3-mutated leukemia cells.

Gilternib 40mg Dosage

The recommended starting dose of gilteritinib for adult patients with FLT3-mutated relapsed or refractory AML is 120mg once daily, taken orally with or without food. Since Gilternib is available as a 40mg tablet, this prescribed dose may correspond to three 40mg tablets per day.

The exact treatment duration and any dose adjustment depend on the patient’s response, laboratory results, side effects, and overall medical condition. Treatment may continue for at least 6 months when there is no disease progression or unacceptable toxicity, because response can sometimes be delayed.

Do not change the dose or number of tablets without your oncologist’s instructions.

How to Take Gilternib 40mg Tablet?

Take Gilternib exactly as prescribed by your doctor.

• Take it orally at approximately the same time every day.
• It can be taken with or without food.
• Swallow the tablets whole.
• Do not break or crush the tablets.
• If a dose is missed, follow your healthcare provider’s instructions. The prescribing information advises not to take two doses within a 12-hour period.

Gilternib 40mg (Gilteritinib) Side Effects

Like other anticancer medicines, Gilternib may cause side effects. Commonly reported reactions with gilteritinib include:

• Fatigue or weakness
• Fever
• Muscle or joint pain
• Nausea
• Diarrhea
• Constipation
• Cough
• Shortness of breath
• Swelling
• Rash
• Headache
• Dizziness
• Changes in liver enzymes
• Eye-related disorders

Not every patient experiences these effects, and their severity can vary.

Serious Side Effects

Gilteritinib can cause serious reactions that require prompt medical attention. One important risk is differentiation syndrome, which can become life-threatening if not treated. Symptoms may include fever, breathing difficulty, rapid weight gain, swelling, low blood pressure, reduced urine output, or fluid around the lungs or heart.

Other important risks include prolonged QT interval, posterior reversible encephalopathy syndrome (PRES), pancreatitis, severe hypersensitivity reactions, and fetal harm during pregnancy.

Seek urgent medical attention if serious or unusual symptoms develop during treatment.

Important Safety Information for Gilternib 40mg

Patients taking gilteritinib require regular medical monitoring. Doctors may monitor blood tests, electrolyte levels, liver-related parameters, and heart rhythm with ECG testing during treatment. The European product information also recommends ECG monitoring at specific stages of therapy.

Patients should tell their doctor about any history of heart rhythm problems, pancreatitis, liver problems, or other significant medical conditions before starting treatment.

Women who can become pregnant should discuss pregnancy prevention with their healthcare provider because gilteritinib may cause fetal harm. Breastfeeding is also not recommended during treatment according to prescribing information.

Gilternib 40mg Precautions

Before taking Gilternib 40mg, inform your doctor about all medicines, supplements, and medical conditions.

Extra caution may be required in patients with:

• Heart rhythm abnormalities
• Low potassium or magnesium
• Liver problems
• Pancreatitis
• Pregnancy or plans for pregnancy
• Breastfeeding
• Previous drug allergies

Regular follow-up is important because dose interruptions or adjustments may be required if significant toxicity develops.

Gilternib 40mg Interactions

Gilteritinib can interact with certain medicines. Strong CYP3A inhibitors may increase gilteritinib exposure, while combined P-gp and strong CYP3A inducers should generally be avoided. Gilteritinib can also affect some medicines that are substrates of P-gp, BCRP, or OCT1.

Always provide your oncologist or pharmacist with a complete list of prescription medicines, over-the-counter products, and supplements before starting treatment.

Gilternib 40mg (Gilteritinib) Price in Pakistan

The Gilternib 40mg Tablet price in Pakistan can vary depending on the supplier, availability, imported stock, pack size, and other market factors. Because anticancer medicines may have changing availability, patients should confirm the current product details and price before placing an order.

For the latest availability and Gilternib 40mg price in Pakistan, contact a reliable medicine supplier such as Impo Medic and confirm the product, strength, packaging, and availability before purchase.

Gilternib 40mg in Pakistan

Gilternib 40mg is an oncology medicine that may be sought by patients receiving treatment for FLT3-mutated AML. Availability of imported or specialized cancer medicines can vary in Pakistan.

Patients should purchase prescription oncology medicines through a reliable source and verify the packaging, strength, manufacturer information, and expiry date before use.

How to Buy Gilternib 40mg in Pakistan?

If you are looking to buy Gilternib 40mg in Pakistan, contact Impo Medic to check current availability and product details. Before ordering, provide the exact medicine name and strength shown on your prescription.

Because gilteritinib is a prescription anticancer medicine, it should only be used according to the treatment plan provided by your oncologist. Impo Medic can help patients and healthcare professionals check product availability and purchasing information.

Why Choose Impo Medic?

Impo Medic focuses on providing useful medicine information for patients looking for pharmaceutical products in Pakistan. For medicines such as Gilternib 40mg, our goal is to make important details about the product, uses, dosage, precautions, side effects, and availability easier to understand.

When purchasing a specialized oncology medicine, patients should always verify the exact product, strength, packaging, and prescription requirements. For current Gilternib 40mg in Pakistan, Impo Medic can be contacted for availability and purchasing information.

Frequently Asked Questions About Gilternib 40mg

What is Gilternib 40mg used for?

Gilternib 40mg contains gilteritinib and is used for certain adults with relapsed or refractory AML that has a confirmed FLT3 mutation.

What is the usual gilteritinib dose?

The recommended starting dose is 120mg once daily. With 40mg tablets, this may equal three tablets daily, but the prescribed dose must come from the treating oncologist.

Can Gilternib 40mg be taken with food?

Yes. Gilteritinib can be taken with or without food. It should be taken at approximately the same time each day.

What are the serious side effects of gilteritinib?

Serious risks include differentiation syndrome, prolonged QT interval, PRES, pancreatitis, severe hypersensitivity reactions, and embryo-fetal toxicity.

Is Gilternib 40mg a chemotherapy medicine?

Gilteritinib is an oral targeted kinase inhibitor rather than traditional cytotoxic chemotherapy. It specifically inhibits targets including FLT3 involved in certain AML cells.

Can I buy Gilternib 40mg in Pakistan without a prescription?

Gilternib is a prescription anticancer medicine. It should be obtained and used under the supervision of a qualified healthcare professional.

Where can I check Gilternib 40mg price in Pakistan?

You can contact Impo Medic to check current availability and pricing information for Gilternib 40mg in Pakistan.

Medical Disclaimer: This information is for educational purposes and should not replace advice from an oncologist or other qualified healthcare professional. Gilteritinib treatment requires appropriate FLT3 testing and medical monitoring.